D-059-2013 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Bridgewater, NJ

FDA drug recall D-059-2013 was initiated by Dr. Reddy's Laboratories, Inc. on Sep 27, 2012 and is designated Class II. Reason for recall: Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg. The recall status is terminated (terminated Jul 10, 2013). Affected quantity: 1512 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 28, 2012
Initiation Date
Sep 27, 2012
Termination Date
Jul 10, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1512 bottles

Product description

Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05

Reason for recall

Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Distribution pattern

Nationwide. No foreign consignees.

Code information

Lot C203090 Exp.03/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-059-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-059-2013. Report a data issue: hello@regdatalab.com.